AbbVie Inc. — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2020-11-04

Reporting Person: SALEKI-GERHARDT AZITA (EVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Common Stock, $0.01 par value	S	4800	$93.61	Disposed	109067	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	2027	Indirect
Common Stock, $0.01 par value	3873	Indirect

Footnotes

F1: This sale was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

F2: Balance in AbbVie Savings program as of February 24, 2020.

F3: The reporting person disclaims beneficial ownership of all securities held by her spouse.